Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rueda, C.
- Puig-Asensio, M.
- Guinea, J.
- Almirante, B.
- Cuenca-Estrella, M.
- Zaragoza, O.
Grupos
Abstract
Objective: Paradoxical growth (PG) and trailing effect (TE) are frequently observed during antifungal susceptibility testing (AFST). These two phenomena interfere with the determination of the minimal inhibitory concentration (MIC). The aim of this study was to assess the clinical impact of TE and PG. Methods: We analysed the frequency of TE and PG of 690 Candida isolates collected froma population-based study performed in Spain (CANDIPOP) and correlated the results with clinical outcome of the patients. Results: Around 70% (484/690) of the isolates exhibited TE to azoles. Candida tropicalis showed the highest presence of TE (39/53 isolates exhibited residual growth > 25% of control). No TE was seen in most of the isolates from the psilosis complex. PG was mainly associated with echinocandins. In patients treated with fluconazole within the first 48 hours after blood sampling (n = 221), the presence of TE to azoles tended to be associated with lower 30-day mortality (odds ratio (OR) 0.55, 95% confidence interval (CI) 0.25-1.00) but not with clinical failure (OR 0.85, 95% CI 0.45-1.54). In the subgroup of 117 patients treated with echinocandins, the presence of PG was not associated with patient's response to antifungal treatment (OR for 30-day mortality 1.63, 95% CI 0.76-4.03; OR for clinical failure 1.17, 95% CI 0.53-2.70). Conclusions: TE or PG are widely expressed among Candida spp., although they do not seem to influence clinical outcome. (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 1198-743X, 1469-0691
- Tipo:
- Article
- Páginas:
- -
- Factor de Impacto:
- 2,569 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
CLINICAL MICROBIOLOGY AND INFECTION ELSEVIER SCI LTD
Citas Recibidas en Web of Science: 32
Documentos
- No hay documentos
Filiaciones
Keywords
- Azoles; Candida; Echinocandins; Paradoxical growth; Trailing effect
Proyectos asociados
FUNGEMIA: EPIDEMIOLOGIA, MECANISMOS DE RESISTENCIA ANTIFUNGICA Y TIPADO MOLECULAR
090/2006- EVES - PEMAN . 2006
NUEVAS ESTRATEGIAS PARA EL TRATAMIENTO DE LAS INFECCIONES ASOCIADAS A BIOCAPAS FUNGICAS.
Investigador Principal: EMILIA CANTON LACASA
PI12/02786 . INSTITUTO DE SALUD CARLOS III . 2013
PHARMAPACKSAFE. DESARROLLO DE ENVASES PLÁSTICOS INERTES Y ESTABLES QUE CONTENDRÁN COLIRIOS PARA USO EN FARMACIA HOSPITALARIA
Investigador Principal: EDUARDO LÓPEZ BRIZ
RTC-2016-5215-1-P03 . MINISTERIO DE CIENCIA E INNOVACION; MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016
ESTUDIO EPIDEMIOLOGICO DE DIAGNOSTICO PRECOZ DE LA CANDIDIASIS INVASORA EN PACIENTES NEONATOS PRETERMINO DE MUY BAJO PESO. ESTUDIO CANDI-NEO
Investigador Principal: MÁXIMO VENTO TORRES
AST-MYC-2010-01
ESTUDIO OBSERVACIONAL, PROSPECTIVO Y MULTICÉNTRICO EN CUIDADOS INTENSIVOS PARA EVALUAR LA FIABILIDAD DIAGNÓSTICOA DE LA PCR (REACCIÓN EN CADENA DE LA POLIMERASA) EN PACIENTES EN TRATAMIENTO ANTIFÚNGICO EMPÍRICO POR SOSPECHA DE CANDIDIASIS INVASIVA. (ESTUD IO MICAFEM).
Investigador Principal: PAULA RAMÍREZ GALLEYMORE
AST-INF-2012-01
Cita
Rueda C,Puig M,Guinea J,Almirante B,Cuenca M,Zaragoza O,CANDIPOP G. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia. Clin Microbiol Infect. 2017. 23. (1):e8. IF:5,394. (1).